1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Wang, G.
Pierens, G.K.
Treleaven, W.D.
Sparrow, J.T.
Cushley, R.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
35
10358
10366
10.1021/bi960934t
8756691
Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR.
1996
10.2210/pdb1oeg/pdb
pdb_00001oeg
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2527.890
APOLIPOPROTEIN E
RESIDUES 267 - 289
1
man
polymer
APOE(267-289), APOLIPOPROTEIN E(267-289)
no
no
PLVEDMQRQWAGLVEKVQAAVGT
PLVEDMQRQWAGLVEKVQAAVGT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1996-12-07
1
1
2008-03-03
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-03-16
REL
REL
5
6.0
310
K
HAVEL
refinement
DGII
PRO
267
n
1
PRO
267
A
LEU
268
n
2
LEU
268
A
VAL
269
n
3
VAL
269
A
GLU
270
n
4
GLU
270
A
ASP
271
n
5
ASP
271
A
MET
272
n
6
MET
272
A
GLN
273
n
7
GLN
273
A
ARG
274
n
8
ARG
274
A
GLN
275
n
9
GLN
275
A
TRP
276
n
10
TRP
276
A
ALA
277
n
11
ALA
277
A
GLY
278
n
12
GLY
278
A
LEU
279
n
13
LEU
279
A
VAL
280
n
14
VAL
280
A
GLU
281
n
15
GLU
281
A
LYS
282
n
16
LYS
282
A
VAL
283
n
17
VAL
283
A
GLN
284
n
18
GLN
284
A
ALA
285
n
19
ALA
285
A
ALA
286
n
20
ALA
286
A
VAL
287
n
21
VAL
287
A
GLY
288
n
22
GLY
288
A
THR
289
n
23
THR
289
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
4
A
A
HD13
HB3
LEU
ASP
268
271
1.21
1
-5.50
0.90
118.30
112.80
A
A
A
CB
CG
OD2
ASP
ASP
ASP
271
271
271
N
1
4.04
0.50
120.30
124.34
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
274
274
274
N
2
-5.47
0.90
118.30
112.83
A
A
A
CB
CG
OD2
ASP
ASP
ASP
271
271
271
N
2
4.01
0.50
120.30
124.31
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
274
274
274
N
3
-5.52
0.90
118.30
112.78
A
A
A
CB
CG
OD1
ASP
ASP
ASP
271
271
271
N
3
4.03
0.50
120.30
124.33
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
274
274
274
N
4
-5.45
0.90
118.30
112.85
A
A
A
CB
CG
OD2
ASP
ASP
ASP
271
271
271
N
4
4.08
0.50
120.30
124.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
274
274
274
N
5
-5.46
0.90
118.30
112.84
A
A
A
CB
CG
OD2
ASP
ASP
ASP
271
271
271
N
5
4.08
0.50
120.30
124.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
274
274
274
N
1
A
A
CD
OE2
GLU
GLU
270
270
0.110
0.011
1.252
1.362
N
1
A
A
CD
OE2
GLU
GLU
281
281
0.109
0.011
1.252
1.361
N
2
A
A
CD
OE2
GLU
GLU
270
270
0.109
0.011
1.252
1.361
N
2
A
A
CD
OE2
GLU
GLU
281
281
0.110
0.011
1.252
1.362
N
3
A
A
CD
OE2
GLU
GLU
270
270
0.110
0.011
1.252
1.362
N
3
A
A
CD
OE1
GLU
GLU
281
281
0.110
0.011
1.252
1.362
N
4
A
A
CD
OE1
GLU
GLU
270
270
0.109
0.011
1.252
1.361
N
4
A
A
CD
OE2
GLU
GLU
281
281
0.110
0.011
1.252
1.362
N
5
A
A
CD
OE2
GLU
GLU
270
270
0.110
0.011
1.252
1.362
N
5
A
A
CD
OE2
GLU
GLU
281
281
0.109
0.011
1.252
1.361
N
1
A
ARG
274
-160.60
-64.27
2
A
GLU
270
-92.50
32.54
2
A
ASP
271
-152.65
37.13
2
A
MET
272
-155.42
29.86
2
A
GLN
273
-154.82
36.70
2
A
ARG
274
-159.68
-63.40
2
A
VAL
287
42.50
70.75
3
A
LEU
268
-99.67
33.28
3
A
VAL
269
-147.80
-49.07
3
A
ASP
271
-95.83
33.78
3
A
MET
272
-148.34
28.53
3
A
GLN
273
-159.61
46.54
3
A
ARG
274
-155.54
-66.54
4
A
LEU
268
-94.91
-106.69
4
A
VAL
269
49.37
21.98
4
A
GLU
270
-142.26
-49.13
4
A
GLN
273
-153.13
45.08
4
A
ARG
274
-153.56
-68.95
4
A
VAL
280
-125.94
-56.84
5
A
GLN
273
-148.96
40.31
5
A
ARG
274
-152.45
-64.20
PEPTIDE OF HUMAN APOE RESIDUES 267-289, NMR, 5 STRUCTURES AT PH 6.0, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:90
1
Y
N
A
LEU
268
A
LEU
2
HELX_P
A
ASP
271
A
ASP
5
1
1
4
A
GLN
275
A
GLN
9
HELX_P
A
ALA
286
A
ALA
20
1
2
12
APOLIPOPROTEIN
SIALIC ACID, HEPARIN-BINDING, DISEASE MUTATION, POLYMORPHISM, APOLIPOPROTEIN
APOE_HUMAN
UNP
1
1
P02649
MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRA
LMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLR
KLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMG
SRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH
285
307
1OEG
267
289
P02649
A
1
1
23
1
P 1